Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy

Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy

Fifty patients with benign prostatic hypertrophy were treated with chlormadinone acetate (CMA) at the dose of 50 mg/day for 12 months. Subjective symptoms and objective findings were evaluated before, and after 4 and 12 months of treatment. Better improvement was observed in all of the subjective sy...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 39(1993), 3 vom: 08. März, Seite 281-7
1. Verfasser: Kogawa, T (VerfasserIn)
Weitere Verfasser: Yanagiya, H, Takashima, T, Higashino, I, Kudo, T, Suzuki, T, Mikuni, T, Kido, K, Tsukui, A, Yagihashi, Y
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1993
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial English Abstract Journal Article Multicenter Study Chlormadinone Acetate 0SY050L61N
LEADER 01000caa a22002652 4500
001 NLM076611310
003 DE-627
005 20250129114303.0
007 tu
008 231222s1993 xx ||||| 00| ||jpn c
028 5 2 |a pubmed25n0256.xml 
035 |a (DE-627)NLM076611310 
035 |a (NLM)7685143 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a jpn 
100 1 |a Kogawa, T  |e verfasserin  |4 aut 
245 1 0 |a Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy 
264 1 |c 1993 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 02.07.1993 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Fifty patients with benign prostatic hypertrophy were treated with chlormadinone acetate (CMA) at the dose of 50 mg/day for 12 months. Subjective symptoms and objective findings were evaluated before, and after 4 and 12 months of treatment. Better improvement was observed in all of the subjective symptoms and in almost all the parameters of objective findings, in proportion to the period of CMA treatment. Generally speaking, 12 months of treatment was more effective than 4 months of treatment. Two patients had impotence (4.0%). Both of them complained of side effects within 4 months after treatment, but they were not severe. In conclusion, long-term treatment of benign prostatic hypertrophy with CMA was useful 
650 4 |a Clinical Trial 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Multicenter Study 
650 7 |a Chlormadinone Acetate  |2 NLM 
650 7 |a 0SY050L61N  |2 NLM 
700 1 |a Yanagiya, H  |e verfasserin  |4 aut 
700 1 |a Takashima, T  |e verfasserin  |4 aut 
700 1 |a Higashino, I  |e verfasserin  |4 aut 
700 1 |a Kudo, T  |e verfasserin  |4 aut 
700 1 |a Suzuki, T  |e verfasserin  |4 aut 
700 1 |a Mikuni, T  |e verfasserin  |4 aut 
700 1 |a Kido, K  |e verfasserin  |4 aut 
700 1 |a Tsukui, A  |e verfasserin  |4 aut 
700 1 |a Yagihashi, Y  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Hinyokika kiyo. Acta urologica Japonica  |d 1962  |g 39(1993), 3 vom: 08. März, Seite 281-7  |w (DE-627)NLM012631779  |x 0018-1994  |7 nnns 
773 1 8 |g volume:39  |g year:1993  |g number:3  |g day:08  |g month:03  |g pages:281-7 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2018 
951 |a AR 
952 |d 39  |j 1993  |e 3  |b 08  |c 03  |h 281-7